Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Biomarkers in Primary Progressive Multiple Sclerosis and Hereditary Spastic Paraplegia Type 4

In patients with slowly progressive spastic paraparesis, the differential diagnosis of primary progressive multiple sclerosis (PPMS) and hereditary spastic paraplegia (HSP) can be challenging. Serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) are promising fluid biom...

Descripción completa

Detalles Bibliográficos
Autores principales: Kessler, Christoph, Ruschil, Christoph, Abdelhak, Ahmed, Wilke, Carlo, Maleska, Aleksandra, Kuhle, Jens, Krumbholz, Markus, Kowarik, Markus C., Schüle, Rebecca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657281/
https://www.ncbi.nlm.nih.gov/pubmed/36362248
http://dx.doi.org/10.3390/ijms232113466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657281/
https://www.ncbi.nlm.nih.gov/pubmed/36362248
http://dx.doi.org/10.3390/ijms232113466

Ejemplares similares